This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

SENSIMED Triggerfish Discomfort During IOP Monitoring (09/02)

This study has been completed.
Information provided by:
Sensimed AG Identifier:
First received: August 24, 2009
Last updated: February 3, 2010
Last verified: February 2010
Evaluation of the wearing discomfort (safety and tolerability) involved during IOP monitoring with the SENISMED Triggerfish, a sensor embedded in a telemetric contact lens

Condition Intervention
Safety and Tolerability of SENSIMED Triggerfish in Glaucoma Patients Device: SENSIMED Triggerfish

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Evaluation of SENSIMED Triggerfish for 24 Hour IOP Monitoring in Healthy Subjects and Glaucoma Patients

Resource links provided by NLM:

Further study details as provided by Sensimed AG:

Primary Outcome Measures:
  • ocular discomfort on a visual analogue scale [ Time Frame: 24 hours ]

Enrollment: 40
Study Start Date: August 2009
Study Completion Date: January 2010
Primary Completion Date: January 2010 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Healthy subjects Device: SENSIMED Triggerfish
Ocular Telemetry Sensor for IOP monitoring
Glaucoma patients Device: SENSIMED Triggerfish
Ocular Telemetry Sensor for IOP monitoring


Ages Eligible for Study:   18 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Healthy subjects and glaucoma patients

Inclusion Criteria:

  • Patient is able to comply with the study procedure
  • Patient is 18-80 years old
  • Healthy subject or glaucoma patient
  • Patient has consented to be in the trial and signed informed consent is available before any study related procedures are carried out
  • Cylinder refraction of no more than +/- 2 diopters in the study eye
  • Visual acuity of 20/80 or better in the study eye
  • Ability of subject to understand the character and individual consequences of the study
  • For women with childbearing potential, adequate contraception

Exclusion Criteria:

  • Subjects wearing contact lenses within the last two years
  • Subjects with contraindications for wearing contact lenses
  • History of refractive surgery
  • History of intraocular surgery in the last three months
  • Severe dry eye syndrome
  • Keratoconus or other corneal abnormalities
  • Conjunctival or intraocular inflammation
  • Pregnancy and lactation
  • Simultaneous participation in other clinical trials
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00966108

Universitätsmedizin der Johannes Gutenberg-Universität Mainz
Mainz, Rheinland-Pfalz, Germany, 55131
Sponsors and Collaborators
Sensimed AG
Principal Investigator: Norbert Pfeiffer, Prof. Dr. med. Universitätsmedizin Mainz
  More Information

Responsible Party: Prof. Dr. med. Norbert Pfeiffer, Universitätsmedizin der Johannes Gutenberg-Universität Mainz Identifier: NCT00966108     History of Changes
Other Study ID Numbers: 09/02
Study First Received: August 24, 2009
Last Updated: February 3, 2010

Additional relevant MeSH terms:
Ocular Hypertension
Eye Diseases processed this record on August 22, 2017